Kezar Life Sciences, Inc. (KZR) Financials

$6.11

south_east
-$0.29 (-4.53%)
Day's range
$6.05
Day's range
$6.4
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80M-$100M-$100M-$120M-$120MEarning20172017201820182019201920202020202120212022202220232023-1453%-1453%-1453.5%-1453.5%-1454%-1454%-1454.5%-1454.5%-1455%-1455%-1455.5%-1455.5%-1456%-1456%-1456.5%-1456.5%Profit Margin
Profit Margin
Revenue
Earnings

KZR Income statement / Annual

Last year (2023), Kezar Life Sciences, Inc.'s total revenue was $7.00 M, and the percentage change from the previous year is not available. In 2023, Kezar Life Sciences, Inc.'s net income was -$101.87 M. See Kezar Life Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $7.00 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $1.07 M $1.02 M $1.51 M $1.54 M $1.30 M $690,000.00 $175,000.00 $154,000.00
Gross Profit $5.93 M -$1.02 M -$1.51 M -$1.54 M -$1.30 M -$690,000.00 -$175,000.00 -$154,000.00
Gross Profit Ratio 0.85 0 0 0 0 0 0 0
Research and Development Expenses $85.70 M $51.01 M $38.94 M $30.98 M $27.36 M $18.14 M $6.47 M $7.37 M
General & Administrative Expenses $26.54 M $20.15 M $15.72 M $11.97 M $9.98 M $6.59 M $2.28 M $1.62 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $26.54 M $20.15 M $15.72 M $11.97 M $9.98 M $6.59 M $2.28 M $1.62 M
Other Expenses $6.19 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $118.42 M $71.16 M $54.66 M $42.95 M $37.34 M $24.73 M $8.75 M $8.99 M
Cost And Expenses $112.24 M $71.16 M $54.66 M $42.95 M $37.34 M $24.73 M $8.75 M $8.99 M
Interest Income $11.10 M $4.11 M $188,000.00 $1.21 M $2.26 M $1.56 M $232,000.00 $0.00
Interest Expense $1.55 M $1.19 M $159,000.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $1.07 M $1.02 M $1.51 M $1.54 M $1.30 M $690,000.00 $175,000.00 $154,000.00
EBITDA -$99.25 M -$66.11 M -$52.96 M -$40.26 M -$34.42 M -$22.48 M -$8.34 M -$8.84 M
EBITDA Ratio -14.18 0 0 0 0 0 0 0
Operating Income Ratio -15.03 0 0 0 0 0 0 0
Total Other Income/Expenses Net $3.37 M $2.92 M $29,000.00 $1.21 M $2.26 M $1.56 M $232,000.00 $0.00
Income Before Tax -$101.87 M -$68.24 M -$54.63 M -$41.74 M -$35.09 M -$23.17 M -$8.52 M -$8.99 M
Income Before Tax Ratio -14.55 0 0 0 0 0 0 0
Income Tax Expense $0.00 -$2.92 M -$1.35 M -$2.75 M -$3.56 M $1.56 M $0.00 $0.00
Net Income -$101.87 M -$65.32 M -$53.28 M -$38.99 M -$31.53 M -$23.17 M -$8.52 M -$8.99 M
Net Income Ratio -14.55 0 0 0 0 0 0 0
EPS -1.4 -0.97 -1.01 -0.89 -1.65 -2.26 -0.65 -0.69
EPS Diluted -1.4 -0.97 -1.01 -0.89 -1.65 -2.26 -0.65 -0.69
Weighted Average Shares Out $72.55 M $67.37 M $52.76 M $44.00 M $19.08 M $10.26 M $13.02 M $13.02 M
Weighted Average Shares Out Diluted $72.55 M $67.37 M $52.76 M $44.00 M $19.08 M $10.26 M $13.02 M $13.02 M
Link